Last reviewed · How we verify
Praziquantel and Albendazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Praziquantel and Albendazole (Praziquantel and Albendazole) — Catholic University of Health and Allied Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Praziquantel and Albendazole TARGET | Praziquantel and Albendazole | Catholic University of Health and Allied Sciences | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Praziquantel and Albendazole CI watch — RSS
- Praziquantel and Albendazole CI watch — Atom
- Praziquantel and Albendazole CI watch — JSON
- Praziquantel and Albendazole alone — RSS
Cite this brief
Drug Landscape (2026). Praziquantel and Albendazole — Competitive Intelligence Brief. https://druglandscape.com/ci/praziquantel-and-albendazole. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab